-1::1
Simple Hit Counter
Skip to content

Products

Solutions

×
×
Sign In

EN

EN - EnglishCN - 简体中文DE - DeutschES - EspañolKR - 한국어IT - ItalianoFR - FrançaisPT - Português do BrasilPL - PolskiHE - עִבְרִיתRU - РусскийJA - 日本語TR - TürkçeAR - العربية
Sign In Start Free Trial

RESEARCH

JoVE Journal

Peer reviewed scientific video journal

Behavior
Biochemistry
Bioengineering
Biology
Cancer Research
Chemistry
Developmental Biology
View All
JoVE Encyclopedia of Experiments

Video encyclopedia of advanced research methods

Biological Techniques
Biology
Cancer Research
Immunology
Neuroscience
Microbiology
JoVE Visualize

Visualizing science through experiment videos

EDUCATION

JoVE Core

Video textbooks for undergraduate courses

Analytical Chemistry
Anatomy and Physiology
Biology
Calculus
Cell Biology
Chemistry
Civil Engineering
Electrical Engineering
View All
JoVE Science Education

Visual demonstrations of key scientific experiments

Advanced Biology
Basic Biology
Chemistry
View All
JoVE Lab Manual

Videos of experiments for undergraduate lab courses

Biology
Chemistry

BUSINESS

JoVE Business

Video textbooks for business education

Accounting
Finance
Macroeconomics
Marketing
Microeconomics

OTHERS

JoVE Quiz

Interactive video based quizzes for formative assessments

Authors

Teaching Faculty

Librarians

K12 Schools

Biopharma

Products

RESEARCH

JoVE Journal

Peer reviewed scientific video journal

JoVE Encyclopedia of Experiments

Video encyclopedia of advanced research methods

JoVE Visualize

Visualizing science through experiment videos

EDUCATION

JoVE Core

Video textbooks for undergraduates

JoVE Science Education

Visual demonstrations of key scientific experiments

JoVE Lab Manual

Videos of experiments for undergraduate lab courses

BUSINESS

JoVE Business

Video textbooks for business education

OTHERS

JoVE Quiz

Interactive video based quizzes for formative assessments

Solutions

Authors
Teaching Faculty
Librarians
K12 Schools
Biopharma

Language

English

EN

English

CN

简体中文

DE

Deutsch

ES

Español

KR

한국어

IT

Italiano

FR

Français

PT

Português do Brasil

PL

Polski

HE

עִבְרִית

RU

Русский

JA

日本語

TR

Türkçe

AR

العربية

    Menu

    JoVE Journal

    Behavior

    Biochemistry

    Bioengineering

    Biology

    Cancer Research

    Chemistry

    Developmental Biology

    Engineering

    Environment

    Genetics

    Immunology and Infection

    Medicine

    Neuroscience

    Menu

    JoVE Encyclopedia of Experiments

    Biological Techniques

    Biology

    Cancer Research

    Immunology

    Neuroscience

    Microbiology

    Menu

    JoVE Core

    Analytical Chemistry

    Anatomy and Physiology

    Biology

    Calculus

    Cell Biology

    Chemistry

    Civil Engineering

    Electrical Engineering

    Introduction to Psychology

    Mechanical Engineering

    Medical-Surgical Nursing

    View All

    Menu

    JoVE Science Education

    Advanced Biology

    Basic Biology

    Chemistry

    Clinical Skills

    Engineering

    Environmental Sciences

    Physics

    Psychology

    View All

    Menu

    JoVE Lab Manual

    Biology

    Chemistry

    Menu

    JoVE Business

    Accounting

    Finance

    Macroeconomics

    Marketing

    Microeconomics

Start Free Trial
Loading...
Home
JoVE Journal
Immunology and Infection
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
JoVE Journal
Immunology and Infection
This content is Free Access.
JoVE Journal Immunology and Infection
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Full Text
41,303 Views
06:38 min
November 8, 2011

DOI: 10.3791/3321-v

Joyce Hui-Yuen1,2, Shane McAllister1,2, Siva Koganti2, Erik Hill2, Sumita Bhaduri-McIntosh1,2,3,4

1Stony Brook Children's Hospital,State University of New York at Stony Brook, 2Department of Pediatrics,State University of New York at Stony Brook, 3Department of Molecular Genetics,State University of New York at Stony Brook, 4Department of Microbiology,State University of New York at Stony Brook

We describe a method for generating transformed B cell lines using Epstein-Barr virus. We also illustrate a novel assay that can identify B cells destined to undergo transformation as early as three days after infection.

The overall goal of this procedure is to generate eps. Epstein-Barr virus transformed Lymphoblasts cell lines or LCL from human B cells. This is accomplished by first isolating peripheral blood mononuclear cells from human blood.

Next, the cells are infected with eps Epstein-Barr virus in the presence of FK 5 0 6 and immunosuppressive agents three to four days after infection with EP Epstein-Barr virus, a subpopulation of cells emerges that is marked as CD 23, high CD 58 positive, and is predicted to undergo proliferation CD 23 high. CD 58 positive cells can be enumerated by flow cytometry as a predictor of successful outcome. Proliferating cells can be further identified, micro and macroscopically by the clusters of lymphoblasts cell lines that form in successfully transformed cell cultures.

The final step is to expand lymphoblasts cell lines for cryo-preservation. In my laboratory, we generate lymphoblasts cell lines or LCLs to understand interactions between the host and Epstein-Barr virus. Lymphoblasts cell lines are also of broad general interest to the scientific community, particularly to virologists immunologists and cancer biologists.

As a postdoctoral O fellow in a du Macintosh lab, I'll be demonstrating the procedure for generating lymphoblasts cell lines. After drawing 10 milliliters of blood from a donor, add the heparinized blood to a 50 milliliter conical tube and then dilute it one to two. By adding 20 milliliters of room temperature PBS to the tube now underlay the diluted blood with 15 milliliters of FICO HIA lymphocytes separation medium, and then spin down the blood at 225 times G without the break at room temperature for 30 minutes to establish a gradient.

Next, remove the buffy coat and transfer it to a new 50 milliliter conical tube. Bring the volume up to 50 milliliters with PBS and then pellet the cells at 600 times G for 10 minutes. Pour off the supinate, re suspend the pellet in 50 milliliters of PBS, and then wash the cells two more times under the same conditions.

Now resuspend the cells in one milliliter of complete RPM. I use five microliters of cells to repair a one to 10 dilution in triam blue, and to count the live cells using a hemo cytometer, then use complete RPMI to adjust the volume to obtain a cell concentration of two times. Center the six cells per milliliter and transfer the cells to a 25 centimeter squared tissue culture flask.

To prepare the cells for infection with Epstein bar virus at FK 5 0 6 to the tissue culture flask to a final concentration of 20 M.Then place the flask in a 5%carbon dioxide incubator at 37 degrees Celsius for one hour. When the cells are almost finished incubating rapidly thaw an aliquot of Epstein bar virus, harvested from B 95 8 cells. Then remove the flask from the incubator and add the EP Epstein bar virus to the cells at one to 10 dilution now swell the flask to mix the epton bar virus into solution, and then place the flask upright in the incubator with the cap on, but slightly loose if using a non vented flask for two to three weeks prior to expansion of the culture for cryo-preservation.

A week after eps, Epstein Barr virus infection, clusters of cells are visible by light microscopy as seen in this representative figure of early microscopic clusters. As time progresses, the microscopic clusters become larger, such that clumps are visible macroscopically in the flask as seen in this figure where larger clusters of LCL can be observed to feed the cells, double the volume of the supportive medium in the culture flask on day 12. When the culture medium turns yellow, typically about once a week, it is generally time to feed the cells to expand the cells, increase the volume of the culture two to three fold.

Using complete RPMI expand the culture to 70 to 100 milliliters in a 75 centimeter square flask over the next few weeks to generate cells for cryopreservation, a successful outcome is predicted by the presence of CD 23, high CD 58 positive cells as seen in this scatterplot, approximately two to 3%of live cells on day three to four after exposure to eps Epstein-Barr virus have this profile other subpopulations of CD 23 positive, CD 23 negative, CD 58 positive and CD 58 negative cells observed after exposure to eps. Epstein-Barr virus show minimal proliferation and uninfected cells or cells infected with a non immortalizing strain of ep. Epstein-Barr virus do not demonstrate CD 23 high.

CD 58 positive cells. The cells may also be visualized by light microscopy. As mentioned, within a week of Epstein-Barr virus infection, small glasses of cells are visible in the flask by light microscopy.

As time progresses and the cells develop into LCL, the microscopic clusters become larger, such that clumps are visible macroscopically in the flask. All right. After watching this video, you should have a good understanding of how to isolate peripheral blood mononuclear cells from human blood and to generate Epstein-Barr virus transformed lymphoblasts cell lines from human B cells, While generation of lymphoblasts cell lines has been described by other laboratories.

The advantage of our protocol is that it provides the researchers with a method to predict successful outcome as early as three to four days after infection of B cells with Epstein-Barr virus.

Explore More Videos

Epstein-Barr VirusGrowth-transformed Lymphoblastoid Cell LinesEBV InfectionB Cell ProliferationImmortalizationEBV LatencyVirus-driven B Cell ProliferationTumorigenesisImmunologic AssaysHuman Monoclonal AntibodiesMitogensPhytohemagglutininLipopolysaccharidePokeweed MitogenCyclosporin AT Cell-mediated KillingHigh Titer EBVImmunosuppressive AgentPeripheral Blood Mononuclear Cells

Related Videos

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

09:40

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Related Videos

20.2K Views

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Related Videos

17.8K Views

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Related Videos

13.4K Views

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Related Videos

9.3K Views

A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines

09:49

A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines

Related Videos

15.5K Views

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Related Videos

9.7K Views

Functional Characterization of Endogenously Expressed Human RYR1 Variants

07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Related Videos

3K Views

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Related Videos

4.7K Views

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

17:59

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Related Videos

12.7K Views

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Related Videos

15.9K Views

JoVE logo
Contact Us Recommend to Library
Research
  • JoVE Journal
  • JoVE Encyclopedia of Experiments
  • JoVE Visualize
Business
  • JoVE Business
Education
  • JoVE Core
  • JoVE Science Education
  • JoVE Lab Manual
  • JoVE Quizzes
Solutions
  • Authors
  • Teaching Faculty
  • Librarians
  • K12 Schools
  • Biopharma
About JoVE
  • Overview
  • Leadership
Others
  • JoVE Newsletters
  • JoVE Help Center
  • Blogs
  • JoVE Newsroom
  • Site Maps
Contact Us Recommend to Library
JoVE logo

Copyright © 2026 MyJoVE Corporation. All rights reserved

Privacy Terms of Use Policies
WeChat QR code